Entact Bio: Funding, Investors & Team (Sep 2026)
Entact Bio is a preclinical stage biotechnology company developing a new class of drugs that enhance the function of beneficial proteins. Launched by a founding team deeply rooted in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development, Entact has designed its proprietary Encompass™ platform to create enhancement-targeting chimeric (ENTAC™) medicines. ENTACs harness the ability of DUBs to regulate proteins. By leveraging this natural cellular mechanism to enhance protein function, Entact is expanding the universe of treatable diseases.
Entact Bio has raised $91.0M across 2 funding rounds on record, the most recent an undisclosed round of $10.0M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Entact Bio Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Entact Bio Funding Rounds
Entact Bio raised $81.0M in a Series A announced in Dec 2022.
3.5 years later, an undisclosed round of $10.0M was announced in Jun 2026.
Entact Bio Founders and Leadership Team
Contact details for the Entact Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Entact Bio Funding Compared to Other Biotechnology Startups
Entact Bio's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Entact Bio in Biotechnology and Watertown
Companies Similar to Entact Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Entact Bio Funding FAQs
What does Entact Bio do?
Entact Bio is a preclinical stage biotechnology company developing a new class of drugs that enhance the function of beneficial proteins. Launched by a founding team deeply rooted in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development, Entact has designed its proprietary Encompass™ platform to create enhancement-targeting chimeric (ENTAC™) medicines. ENTACs harness the ability of DUBs to regulate proteins. By leveraging this natural cellular mechanism to enhance protein function, Entact is expanding the universe of treatable diseases.
How much funding has Entact Bio raised?
Entact Bio has raised $91.0M across 2 rounds on record. The most recent is an undisclosed round of $10.0M announced in Jun 2026.
When did Entact Bio last raise funding?
Entact Bio's most recent funding round on record is an undisclosed round of $10.0M, announced in Jun 2026.
Who is the CEO of Entact Bio?
Victoria Richon is listed as CEO at Entact Bio.
Where is Entact Bio headquartered?
Entact Bio is based in Watertown, Massachusetts, United States.
How many employees does Entact Bio have?
Entact Bio is in the 11-50 employee band.
How does Entact Bio's funding compare to other Biotechnology startups?
Entact Bio's latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Entact Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Entact Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.